JPH0797384A - Silicone-based hydantoin derivative, ultraviolet light absorber and external preparation for skin - Google Patents
Silicone-based hydantoin derivative, ultraviolet light absorber and external preparation for skinInfo
- Publication number
- JPH0797384A JPH0797384A JP5265839A JP26583993A JPH0797384A JP H0797384 A JPH0797384 A JP H0797384A JP 5265839 A JP5265839 A JP 5265839A JP 26583993 A JP26583993 A JP 26583993A JP H0797384 A JPH0797384 A JP H0797384A
- Authority
- JP
- Japan
- Prior art keywords
- silicone
- formula
- skin
- hydantoin derivative
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001296 polysiloxane Polymers 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000006097 ultraviolet radiation absorber Substances 0.000 title claims abstract description 5
- 150000001469 hydantoins Chemical class 0.000 title claims description 24
- 229940124543 ultraviolet light absorber Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 17
- -1 glycine Chemical class 0.000 claims abstract description 16
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 8
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 4
- 125000005702 oxyalkylene group Chemical group 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 19
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 abstract description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 6
- 229940091173 hydantoin Drugs 0.000 abstract description 6
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 abstract description 4
- 239000004471 Glycine Substances 0.000 abstract description 3
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract description 2
- 150000002367 halogens Chemical class 0.000 abstract description 2
- 229920002545 silicone oil Polymers 0.000 abstract description 2
- 230000031700 light absorption Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 30
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 20
- 239000003921 oil Substances 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000006096 absorbing agent Substances 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- NKQBXYVAZTZVMV-YVMONPNESA-N (5z)-5-[(3,4-dimethoxyphenyl)methylidene]imidazolidine-2,4-dione Chemical compound C1=C(OC)C(OC)=CC=C1\C=C/1C(=O)NC(=O)N\1 NKQBXYVAZTZVMV-YVMONPNESA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000003935 benzaldehydes Chemical class 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- BXVSAYBZSGIURM-UHFFFAOYSA-N 2-phenoxy-4h-1,3,2$l^{5}-benzodioxaphosphinine 2-oxide Chemical compound O1CC2=CC=CC=C2OP1(=O)OC1=CC=CC=C1 BXVSAYBZSGIURM-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- ZFJFYUXFKXTXGT-UHFFFAOYSA-N [dimethyl(methylsilyloxy)silyl]oxy-[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilane Chemical compound C[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ZFJFYUXFKXTXGT-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 125000003354 benzotriazolyl group Chemical class N1N=NC2=C1C=CC=C2* 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、新規なシリコーン系ヒ
ダントイン誘導体、紫外線吸収剤及び皮膚外用剤に関す
る。さらに詳しくは、シリコーン油に溶解し、耐水及び
耐油性に優れ、かつUV−A領域の波長の紫外線吸収特
性を有する新規なシリコーン系ヒダントイン誘導体に関
するものである。TECHNICAL FIELD The present invention relates to a novel silicone-based hydantoin derivative, an ultraviolet absorber and a skin external preparation. More specifically, the present invention relates to a novel silicone-based hydantoin derivative which is soluble in silicone oil, has excellent water resistance and oil resistance, and has ultraviolet absorption characteristics in the wavelength range of UV-A.
【0002】[0002]
【従来の技術】紫外線は、様々な変化を皮膚にもたらす
ことが知られている。紫外線を皮膚科学的に分類すると
400〜320nmのUV−Aと呼ばれる長波長紫外線、
320〜290nmのUV−Bと呼ばれる中波長紫外線、
290nm以下のUV−Cと呼ばれる短波長紫外線とに分
けられる。通常、人間が曝露される紫外線の大部分は太
陽光線であるが、地上に届く紫外線はUV−AおよびU
V−BでUV−Cはオゾン層において吸収されて地上に
は殆ど達しない。地上にまで達する紫外線の中でUV−
Bは皮膚の紅斑や水泡を生じ、またUV−Aは、皮膚の
黒化をもたらし、長期にわたって作用したときには皮膚
の老化を促進することが認められている。BACKGROUND OF THE INVENTION Ultraviolet light is known to cause various changes in the skin. When UV rays are dermatologically classified, 400-320 nm long-wavelength UV rays called UV-A,
Mid-wavelength ultraviolet light called UV-B from 320 to 290 nm,
It is divided into short wavelength ultraviolet rays called UV-C having a wavelength of 290 nm or less. Normally, most of the ultraviolet rays that humans are exposed to are the sun's rays, but the ultraviolet rays that reach the ground are UV-A and U.
In V-B, UV-C is absorbed in the ozone layer and hardly reaches the ground. UV- in the ultraviolet that reaches the ground
B has been found to cause erythema and blisters on the skin, and UV-A has been shown to cause blackening of the skin and promote skin aging when acted over a long period of time.
【0003】従来、UV−B吸収剤は数多く開発されて
きたが、UV−Aは、むしろ夏の海辺で皮膚を健康的な
小麦色にする紫外線として受け入れられていたところか
ら、それほど注目されていなかった。しかし、近年に
は、四季を通じて白い肌であることへの消費者の要望が
高まったことと、皮膚の老化を防ぐことをも併せて、U
V−A吸収剤が注目されるようになってきている。Although many UV-B absorbers have been developed in the past, UV-A has received much attention because it has been accepted as ultraviolet rays that make the skin a healthy wheat color at the seaside in summer. There wasn't. However, in recent years, along with increasing consumer demand for white skin throughout the four seasons and preventing skin aging,
VA absorbers are gaining attention.
【0004】既存のUV−A吸収剤としては、ベンゾフ
ェノン誘導体、ジベンゾイルメタン誘導体、ベンゾトリ
アゾール誘導体などが知られており、化粧料、医薬部外
品等の外用剤に配合され利用されてきた。As existing UV-A absorbers, benzophenone derivatives, dibenzoylmethane derivatives, benzotriazole derivatives and the like are known, and they have been used by being blended with external preparations such as cosmetics and quasi drugs.
【0005】一方、近年紫外線吸収剤の配合される化粧
料には、その効果を持続させる必要上、汗や水浴によっ
て容易に流れ落ちしない耐水および耐油性に優れたジメ
チルシロキサン等のシリコーン系基剤が広く使用される
ようになってきた。これは、シリコーン系基剤の耐水お
よび耐油性機能はもちろん、伸びのよさ、さっぱり感、
べとつかない等の使用性によるところも大きい。On the other hand, in recent years, cosmetics containing ultraviolet absorbers have a silicone base such as dimethylsiloxane which is excellent in water resistance and oil resistance and does not easily run off by sweat or a water bath in order to maintain its effect. It has become widely used. This is not only water- and oil-resistant function of silicone base, but also good elongation, refreshing feeling,
It is also largely due to usability such as non-greasiness.
【0006】しかしながら、既存のUV−A吸収剤はシ
リコーン系基剤に対する相溶性が著しく低い。したがっ
て、シリコーン系基剤を配合した外用剤は、従来のUV
−A吸収剤を併せて配合することが困難となり、その使
用量も極く少量に限られ、UV−A吸収剤の持つ機能が
十分に発揮されないという欠点があった。However, the existing UV-A absorbers have extremely low compatibility with silicone bases. Therefore, the external preparation containing the silicone base is
It is difficult to mix the -A absorber together, and the amount used is very small, which is a drawback that the UV-A absorber does not exhibit its full function.
【0007】そのため、シリコーン系基剤に溶解し、耐
水性に優れ、UV−A領域の紫外線から皮膚を保護する
UV−A吸収剤の開発が強く望まれるようになった。Therefore, it has been strongly desired to develop a UV-A absorber which is soluble in a silicone base, has excellent water resistance, and protects the skin from ultraviolet rays in the UV-A region.
【0008】本発明者は、かかる実情に鑑み鋭意研究を
行った結果、シリコーン系ヒダントイン誘導体が、上述
の性質を満足し得る化合物であることを見いだし、本発
明を完成するに至った。As a result of earnest studies in view of such circumstances, the present inventor has found that a silicone-based hydantoin derivative is a compound which can satisfy the above-mentioned properties, and has completed the present invention.
【0009】[0009]
【発明が解決しようとする課題】すなわち、本発明の目
的は、シリコーン系基剤に溶解するとともに、UV−A
領域の紫外線を吸収する物質及びそれを配合した皮膚外
用剤を提供することにある。That is, the object of the present invention is to dissolve UV-A in a silicone base and
It is intended to provide a substance that absorbs ultraviolet rays in the region and a skin external preparation containing the substance.
【0010】[0010]
【課題を解決するための手段】この目的は一般式化2で
表される単位を少なくとも一個持つシロキサン類であっ
て、前記シロキサン中に存在し得る他の単位が、一般式
O(4-n)/2 SiR4 n、で表されることを特徴とするシ
リコーン系ヒダントイン誘導体、該シリコーン系ヒダン
トイン誘導体からなる紫外線吸収剤及び該シリコーン系
ヒダントイン誘導体を含有することを特徴とする皮膚外
用剤によって達成される。This object is siloxanes having at least one unit represented by the general formula 2, and other units which may be present in the siloxane are represented by the general formula O (4-n ) / 2 SiR 4 n , a silicone-based hydantoin derivative represented by To be done.
【0011】[0011]
【化2】 [Chemical 2]
【0012】以下、本発明の構成について詳述する。The structure of the present invention will be described in detail below.
【0013】本発明のシリコーン系ヒダントイン誘導体
の式中に定義したR1 、R4 の例としては、メチル、エ
チル、n−プロピル、イソプロピル、n−ブチル、イソ
ブチル、t−ブチル、フェニル基、トリメチルシロキシ
基等があげられる。mはR1の置換数を表し0〜3の整
数である。また、nはR4 の置換数を表し1〜3の整数
である。R2 およびR3 の例としては、例えば、−CH
2 −、−(CH2 )2 −、−(CH2 )3 − 、−CH
2 CH(CH3 )CH2 − 、−CH2 CH2 CH(C
H3 )− 、−CH(CH3 )CH2 CH2 − 、−C
(CH3 )2 CH2 CH2 −、−(CH2 )5 −−CH
2 CH2 CH2 CH(CH2 CH3 )−、−CH2 CH
2 CH2 CH2 CH(CH3 )−、−(CH2 )7 −、
−CH2 CH2 OCH2 CH2 −、−CH2 CH2 CH
2 OCH2 −、等があげられる。Xの例としては、メト
キシ、エトキシ、イソプロポキシ、ブトキシ、t−ブト
キシ、ヘキシロキシ、オクチロキシ等があげられる。a
はXの置換数を表し0〜5の整数である。Examples of R 1 and R 4 defined in the formula of the silicone hydantoin derivative of the present invention are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, phenyl group and trimethyl. Examples thereof include siloxy group. m represents the number of substitutions of R 1 and is an integer of 0 to 3. In addition, n represents the number of substitutions of R 4 and is an integer of 1 to 3. Examples of R 2 and R 3 include, for example, —CH
2 -, - (CH 2) 2 -, - (CH 2) 3 -, -CH
2 CH (CH 3) CH 2 -, -CH 2 CH 2 CH (C
H 3) -, -CH (CH 3) CH 2 CH 2 -, -C
(CH 3) 2 CH 2 CH 2 -, - (CH 2) 5 --CH
2 CH 2 CH 2 CH (CH 2 CH 3) -, - CH 2 CH
2 CH 2 CH 2 CH (CH 3) -, - (CH 2) 7 -,
-CH 2 CH 2 OCH 2 CH 2 -, - CH 2 CH 2 CH
2 OCH 2 −, and the like. Examples of X include methoxy, ethoxy, isopropoxy, butoxy, t-butoxy, hexyloxy, octyloxy and the like. a
Represents the number of substitutions of X and is an integer of 0-5.
【0014】本発明のシリコーン系ヒダントイン誘導体
は、例えば次の方法により製造することができる。The silicone hydantoin derivative of the present invention can be produced, for example, by the following method.
【0015】[0015]
【化3】 [Chemical 3]
【0016】ベンズアルデヒド誘導体(2)とヒダント
イン(3)をグリシン、アラニン等のアミノ酸またはそ
の塩の存在下、水あるいは水性溶液中で室温〜150℃
で1〜20時間反応させて(4)を得る。次いで、
(4)をN,N−ジメチルホルムアミド、ジメチルスル
ホキシド等の溶媒中、KOH、NaOH、K2 CO3 等
の塩基の存在下、シリコーン化合物A〔化4(R1 は炭
素数1〜4のアルキル基、フェニル基またはトリメチル
シロキシ基、R2 およびR3 はアルキレン基またはオキ
シアルキレン基、YはBr、Cl、I等のハロゲン元素
を表す。また、mは0〜3の整数を表す。)で表される
単位を少なくとも1個持つシロキサン類であって、前記
シロキサン類中に存在し得る他の単位が、一般式O
(4-n)/2 SiR4 n (nは0〜3の整数、R4 は炭素数
1〜4のアルキル基、フェニル基またはトリメチルシロ
キシ基を表す。)で表される化合物である。〕と室温〜
200℃で5分〜50時間反応させることにより(1)
を得ることができる。The benzaldehyde derivative (2) and hydantoin (3) are added in the presence of amino acids such as glycine and alanine or salts thereof in water or an aqueous solution at room temperature to 150 ° C.
At room temperature for 1 to 20 hours to obtain (4). Then
(4) in a solvent such as N, N-dimethylformamide or dimethylsulfoxide in the presence of a base such as KOH, NaOH or K 2 CO 3 to give a silicone compound A [Chemical Formula 4 (R 1 is an alkyl group having 1 to 4 carbon atoms] Group, a phenyl group or a trimethylsiloxy group, R 2 and R 3 represent an alkylene group or an oxyalkylene group, Y represents a halogen element such as Br, Cl, I. Further, m represents an integer of 0 to 3). Siloxane having at least one unit represented, and other units which may be present in the siloxane are represented by the general formula O
It is a compound represented by (4-n) / 2 SiR 4 n (n is an integer of 0 to 3, R 4 represents an alkyl group having 1 to 4 carbon atoms, a phenyl group or a trimethylsiloxy group). ] And room temperature ~
By reacting at 200 ° C. for 5 minutes to 50 hours (1)
Can be obtained.
【0017】[0017]
【化4】 [Chemical 4]
【0018】あるいは、(4)をN,N−ジメチルホル
ムアミド、ジメチルスルホキシド等の溶媒中、KOH、
NaOH、K2 CO3 等の塩基の存在下、シリコーン化
合物B〔化5(R1 は炭素数1〜4のアルキル基、フェ
ニル基またはトリメチルシロキシ基、R2 はアルキレン
基またはオキシアルキレン基、Zは水素原子、メチル基
を表す。また、mは0〜3の整数を表す。)で表される
単位を少なくとも1個持つシロキサン類であって、前記
シロキサン類中に存在し得る他の単位が、一般式O
(4-n)/2 SiR4 n (nは0〜3の整数、R4 は炭素数
1〜4のアルキル基、フェニル基またはトリメチルシロ
キシ基を表す。)で表される化合物である。〕と室温〜
150℃で30分〜50時間反応させることにより
(1)を得ることもできる。Alternatively, (4) is added with KOH, in a solvent such as N, N-dimethylformamide or dimethylsulfoxide.
In the presence of a base such as NaOH or K 2 CO 3 , the silicone compound B [Chemical formula 5 (R 1 is an alkyl group having 1 to 4 carbon atoms, a phenyl group or a trimethylsiloxy group, R 2 is an alkylene group or an oxyalkylene group, Z Represents a hydrogen atom or a methyl group, and m represents an integer of 0 to 3), which is a siloxane having at least one unit represented by the following formula. , General formula O
It is a compound represented by (4-n) / 2 SiR 4 n (n is an integer of 0 to 3, R 4 represents an alkyl group having 1 to 4 carbon atoms, a phenyl group or a trimethylsiloxy group). ] And room temperature ~
(1) can also be obtained by reacting at 150 ° C. for 30 minutes to 50 hours.
【0019】[0019]
【化5】 [Chemical 5]
【0020】本発明の皮膚外用剤に用いる基剤は、シリ
コーン系ヒダントイン誘導体が溶解するものであれば何
れでも良いが、特にシリコーン系基剤が、伸びの良さ、
さっぱり感、べとつかない等の使用感や優れた耐水性、
耐油性、さらには汗や水に流れにくいなどの機能が得ら
れるので好ましい。The base used in the external preparation for skin of the present invention may be any as long as the silicone-based hydantoin derivative can be dissolved therein. In particular, the silicone-based base has excellent elongation,
A feeling of freshness, a feeling of non-greasiness and excellent water resistance,
It is preferable because it provides oil resistance and further functions such as difficulty in flowing into sweat and water.
【0021】シリコーン系基剤には特に制限はないが、
例えばジメチルポリシロキサン、メチルポリシロキサ
ン、メチルハイドロジェンポリシロキサン等の鎖状ポリ
シロキサン、デカメチルポリシロキサン、ドデカメチル
ポリシロキサン、テトラメチルテトラハイドロジェンポ
リシロキサン等の環状ポリシロキサン、ポリエーテル脂
肪酸変性ポリシロキサン、高級アルコール変性ポリシロ
キサン、アミノ酸変性ポリシロキサン等が用いられる。The silicone base is not particularly limited,
For example, chain polysiloxanes such as dimethylpolysiloxane, methylpolysiloxane, and methylhydrogenpolysiloxane, cyclic polysiloxanes such as decamethylpolysiloxane, dodecamethylpolysiloxane, tetramethyltetrahydrogenpolysiloxane, and polyether fatty acid-modified polysiloxane. , Higher alcohol-modified polysiloxane, amino acid-modified polysiloxane and the like are used.
【0022】なお、本発明の皮膚外用剤には、通常化粧
品や医薬部外品等の皮膚外用剤に用いられる他の成分、
例えば、油分、潤滑油、本発明以外の紫外線吸収剤、酸
化防止剤、界面活性剤、防腐剤、金属封鎖剤、香料、
水、アルコール、増粘剤等を必要に応じて適宜配合する
ことができる。本発明の皮膚外用剤は、特にその適用分
野を限定するものではなく、本発明に用いるシリコーン
系ヒダントイン誘導体の特性と目的に応じ、化粧料、医
薬部外品等に利用され得るものである。The external preparation for skin of the present invention contains other ingredients usually used for external preparations for skin such as cosmetics and quasi drugs.
For example, oil, lubricating oil, ultraviolet absorbers other than the present invention, antioxidants, surfactants, preservatives, sequestering agents, perfumes,
Water, alcohol, a thickener and the like can be appropriately blended as necessary. The external preparation for skin of the present invention is not particularly limited in its field of application, and can be used in cosmetics, quasi drugs and the like depending on the characteristics and purpose of the silicone hydantoin derivative used in the present invention.
【0023】ここで、本発明の皮膚外用剤の剤型は任意
であり、パウダー状、クリーム状、ペースト状、スチッ
ク状、液状、スプレー状、ファンデーション状等、何れ
の剤型でもかまわず、また乳化剤を用いてW/O型ある
いはO/W型に乳化しても良い。その配合量は上記の剤
型によっても異なるが、一般には、0.1〜30重量%
が好ましく、更に好ましくは0.2〜20重量%であ
る。Here, the dosage form of the external preparation for skin of the present invention is arbitrary, and any dosage form such as powder, cream, paste, stick, liquid, spray, foundation, etc. may be used. You may emulsify to a W / O type or an O / W type using an emulsifier. The blending amount varies depending on the above dosage form, but is generally 0.1 to 30% by weight.
Is preferable, and more preferably 0.2 to 20% by weight.
【0024】[0024]
【実施例】次に実施例をあげて本発明をさらに説明す
る。なお、本発明は、これらによって限定されるもので
はない。EXAMPLES The present invention will be further described with reference to examples. The present invention is not limited to these.
【0025】実施例1 (1)3,4−ジメトキシベンズアルデヒド83.0
g、ヒダントイン50.0g、グリシン28.1g、水
酸化ナトリウム7.5g、水200mlを約75℃で8時
間撹拌した。冷却後、得られた結晶をろ取し、水洗後乾
燥し、5−(3,4−ジメトキシベジリデン)ヒダント
イン112.4g(収率90.6%)を得た。Example 1 (1) 3,4-dimethoxybenzaldehyde 83.0
g, hydantoin 50.0 g, glycine 28.1 g, sodium hydroxide 7.5 g, and water 200 ml were stirred at about 75 ° C. for 8 hours. After cooling, the obtained crystals were collected by filtration, washed with water and dried to give 5- (3,4-dimethoxybenzylidene) hydantoin 112.4 g (yield 90.6%).
【0026】(2)N,N−ジメチルホルムアミド(D
MF)100mlに、上記5−(3,4−ジメトキシベジ
リデン)ヒダントイン12.40g、下記化6で示され
るシリコーン化合物25.32g、水酸化ナトリウム
0.4gを約120℃で3時間撹拌した。(2) N, N-dimethylformamide (D
To 100 ml of MF), 12.40 g of the above 5- (3,4-dimethoxybenzylidene) hydantoin, 25.32 g of the silicone compound represented by the following chemical formula 6, and 0.4 g of sodium hydroxide were stirred at about 120 ° C. for 3 hours.
【0027】[0027]
【化6】 [Chemical 6]
【0028】(3)冷却後、減圧下でDMFを留去し、
微黄色の固体を得た。この固体をメタノールから再結晶
し、下記化7で示される本発明のシリコーン系ヒダント
イン誘導体20.77g(収率62.0%)を得た。(3) After cooling, DMF was distilled off under reduced pressure,
A slightly yellow solid was obtained. This solid was recrystallized from methanol to obtain 20.77 g (yield 62.0%) of the silicone-based hydantoin derivative of the present invention represented by the following Chemical formula 7.
【0029】[0029]
【化7】 [Chemical 7]
【0030】実施例2 (1)シリコーン化合物化6を下記化8で示されるシリ
コーン化合物24.48gに変えた他は実施例1に準じ
て反応を行い、Example 2 (1) The reaction was carried out in the same manner as in Example 1 except that 24.48 g of the silicone compound represented by the following chemical formula 8 was changed from the chemical compound 6 shown below.
【0031】[0031]
【化8】 [Chemical 8]
【0032】(2)下記化9で示される本発明のシリコ
ーン系ヒダントイン誘導体19.12g(収率58.3
%)を得た。(2) 19.12 g of the silicone-based hydantoin derivative of the present invention represented by the following chemical formula 9 (yield 58.3)
%) Was obtained.
【0033】[0033]
【化9】 [Chemical 9]
【0034】実施例3 (1)N,N−ジメチルホルムアミド(DMF)100
mlに実施例1で得た5−(3,4−ジメトキシベジリデ
ン)ヒダントイン12.40g、下記化10で示される
シリコーン化合物19.23gを約120℃で5時間撹
拌した。Example 3 (1) N, N-dimethylformamide (DMF) 100
12.40 g of 5- (3,4-dimethoxybenzylidene) hydantoin obtained in Example 1 and 19.23 g of a silicone compound represented by the following chemical formula 10 were stirred in ml at about 120 ° C. for 5 hours.
【0035】[0035]
【化10】 [Chemical 10]
【0036】(2)冷却後、減圧下でDMFを留去し
た。残分についてメタノールから再結晶し、下記化11
で示れる本発明のシリコーン系ヒダントイン誘導体1
8.12g(収率60.8%)を得た。(2) After cooling, DMF was distilled off under reduced pressure. The residue was recrystallized from methanol and
The silicone-based hydantoin derivative 1 of the present invention represented by
8.12 g (yield 60.8%) was obtained.
【0037】[0037]
【化11】 [Chemical 11]
【0038】実施例4 (1)N,N−ジメチルホルムアミド(DMF)100
mlに実施例1で得た5−(3,4−ジメトキシベジリデ
ン)ヒダントイン4.96g、下記化12で示されるシ
リコーン化合物8.82gを約120℃で3時間撹拌し
た。Example 4 (1) N, N-Dimethylformamide (DMF) 100
4-96 g of 5- (3,4-dimethoxybenzylidene) hydantoin obtained in Example 1 and 8.82 g of a silicone compound represented by the following Chemical formula 12 were stirred in 120 ml at about 120 ° C. for 3 hours.
【0039】[0039]
【化12】 [Chemical 12]
【0040】(2)冷却後、減圧下でDMFを留去し
た。残分についてシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=7:3)で精製を行い、下記
化13で示れる本発明のシリコーン系ヒダントイン誘導
体6.97g(収率53.7%)を得た。(2) After cooling, DMF was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 7: 3) to obtain 6.97 g (yield 53.7%) of the silicone-based hydantoin derivative of the present invention represented by the following chemical formula 13.
【0041】[0041]
【化13】 [Chemical 13]
【0042】なお、化7、化9、化11、化13の構造
は、 1H−NMRスペクトル、赤外吸収スペクトルによ
り確認した。The structures of Chemical formula 7, Chemical formula 9, Chemical formula 11, and Chemical formula 13 were confirmed by 1 H-NMR spectrum and infrared absorption spectrum.
【0043】1H−NMRスペクトルは、JNM FX
−270(日本電子株式会社製)を用いて、CDCl3
を溶媒(内部基準CHCl3 ) として測定を行った。代
表例として、図1に化7の 1H−NMRスペクトルを示
す。The 1H-NMR spectrum is shown by JNM FX.
-270 (manufactured by JEOL Ltd.) using CDCl 3
Was used as a solvent (internal standard CHCl 3 ). As a representative example, the 1 H-NMR spectrum of Chemical formula 7 is shown in FIG.
【0044】赤外吸収スペクトルは、270−30赤外
分光光度計(日立製作所製)を用いて臭化カリウム錠剤
法で測定を行った。代表例として、図2に化7の赤外吸
収スペクトルを示す。The infrared absorption spectrum was measured by the potassium bromide tablet method using a 270-30 infrared spectrophotometer (manufactured by Hitachi Ltd.). As a typical example, the infrared absorption spectrum of Chemical formula 7 is shown in FIG.
【0045】実施例1〜4で得た化合物について、UV
−2200型分光光度計(島津製作所製)を用いてエタ
ノール溶媒で紫外線吸収スペクトルを測定したところ、
何れもUV−A領域に極大吸収を示した。このことよ
り、本発明のシリコーン系ヒダントイン誘導体は、優れ
たUV−A吸収剤であるといえる。代表例として、図3
に化7の紫外線吸収スペクトルを示す。For the compounds obtained in Examples 1 to 4, UV
-2200 spectrophotometer (manufactured by Shimadzu Corporation) was used to measure the ultraviolet absorption spectrum with an ethanol solvent,
All showed maximum absorption in the UV-A region. From this, it can be said that the silicone hydantoin derivative of the present invention is an excellent UV-A absorber. As a typical example, FIG.
2 shows the ultraviolet absorption spectrum of Chemical formula 7.
【0046】本発明のシリコーン系ヒダントイン誘導体
のシリコーン系基剤に対する溶解性は、25℃の条件
下、ジメチルポリシロキサン、メチルフェニルポリシロ
キサンへの溶解性を試験した。いずれも、10重量%以
上溶解し、優れた溶解性を示した。Regarding the solubility of the silicone-based hydantoin derivative of the present invention in the silicone-based base, the solubility in dimethylpolysiloxane and methylphenylpolysiloxane was tested under the condition of 25 ° C. In each case, 10% by weight or more was dissolved and excellent solubility was exhibited.
【0047】また、耐水性・耐油性は、水、50%エタ
ール、流動パラフィン等の油に本発明のシリコーン系ヒ
ダントイン誘導体を撹拌混合し、50℃にて60日間放
置した。その結果、加水分解等は起こらず、耐水性、耐
油性が優れていることを確認した。With respect to water resistance and oil resistance, the silicone hydantoin derivative of the present invention was stirred and mixed with oil such as water, 50% etal and liquid paraffin, and the mixture was allowed to stand at 50 ° C. for 60 days. As a result, it was confirmed that hydrolysis and the like did not occur and the water resistance and oil resistance were excellent.
【0048】 実施例5 日焼け止め化粧料(油状タイプ) (1)デカメチルシクロペンタシロキサン 48.0重量部 (2)ジメチルポリシロキサン(10cs/25℃) 20.0 (3)メチルフェニルポリシロキサン(20cs/25℃) 20.0 (4)シリコーン樹脂 10.0 (5)シリコーン系ヒダントイン誘導体(実施例1の化合物) 2.0Example 5 Sunscreen Cosmetic (Oil Type) (1) Decamethylcyclopentasiloxane 48.0 parts by weight (2) Dimethylpolysiloxane (10 cs / 25 ° C.) 20.0 (3) Methylphenylpolysiloxane ( 20cs / 25 ° C) 20.0 (4) Silicone resin 10.0 (5) Silicone-based hydantoin derivative (compound of Example 1) 2.0
【0049】(製法)(1)〜(5)を混合し、十分に
溶解した後、ろ過して製品とした。(Production method) (1) to (5) were mixed, sufficiently dissolved, and then filtered to obtain a product.
【0050】比較例1 実施例5の処方中、(5)を除く以外は実施例5と同様
にして製品を得た。Comparative Example 1 A product was obtained in the same manner as in Example 5 except that (5) was excluded from the formulation of Example 5.
【0051】 実施例6 日焼け止め化粧料(クリーム) (1)デカメチルペンタシロキサン 9.0重量部 (2)流動パラフィン 3.0 (3)イソプロピルミリステート 2.0 (4)ワセリン 5.0 (5)セタノール 5.0 (6)ステアリン酸 3.0 (7)グリセリルモノイソステアレート 3.0 (8)シリコーン系ヒダントイン誘導体(実施例2の化合物) 2.0 (9)防腐剤 0.2 (10)香料 0.2 (11)グリセリン 10.0 (12)プロピレングリコール 5.0 (13)水酸化カリウム 0.2 (14)精製水 52.4Example 6 Sunscreen Cosmetic (Cream) (1) Decamethylpentasiloxane 9.0 parts by weight (2) Liquid paraffin 3.0 (3) Isopropyl myristate 2.0 (4) Vaseline 5.0 ( 5) Cetanol 5.0 (6) Stearic acid 3.0 (7) Glyceryl monoisostearate 3.0 (8) Silicone hydantoin derivative (Compound of Example 2) 2.0 (9) Preservative 0.2 (10) Fragrance 0.2 (11) Glycerin 10.0 (12) Propylene glycol 5.0 (13) Potassium hydroxide 0.2 (14) Purified water 52.4
【0052】(製法)(1)〜(10)を70℃で加熱
撹拌して油相部とした。(11)〜(14)を70℃に
加熱し完全溶解した後、水相部とした。油相部を水相部
に添加し、乳化機にて乳化した。乳化物を30℃まで冷
却し製品とした。(Production method) (1) to (10) were heated and stirred at 70 ° C. to obtain an oil phase part. (11) to (14) were heated to 70 ° C. to completely dissolve them and then used as an aqueous phase part. The oil phase part was added to the water phase part and emulsified with an emulsifier. The emulsion was cooled to 30 ° C. to obtain a product.
【0053】比較例2 実施例6の処方中(8)を除く以外は実施例6と同様に
して製品を得た。Comparative Example 2 A product was obtained in the same manner as in Example 6 except that (8) was excluded from the formulation of Example 6.
【0054】 実施例7 日焼け止めローション (1)ジメチルポリシロキサン(5cs/25℃) 10.0重量部 (2)メチルフェニルポリシロキサン(20cs/25℃) 7.0 (3)ステアリン酸 1.0 (4)シリコーン系ヒダントイン誘導体(実施例3の化合物) 10.0 (5)防腐剤 0.2 (6)香料 0.2 (7)グリセリン 5.0 (8)水酸化カリウム 0.2 (9)精製水 66.4Example 7 Sunblock Lotion (1) Dimethylpolysiloxane (5cs / 25 ° C) 10.0 parts by weight (2) Methylphenylpolysiloxane (20cs / 25 ° C) 7.0 (3) Stearic acid 1.0 (4) Silicone-based hydantoin derivative (compound of Example 3) 10.0 (5) Preservative 0.2 (6) Perfume 0.2 (7) Glycerin 5.0 (8) Potassium hydroxide 0.2 (9) ) Purified water 66.4
【0055】(製法)(1)〜(6)を70℃で加熱撹
拌して油相部とした。(7)〜(9)を70℃に加熱し
完全溶解した後、水相部とした。油相部を水相部に添加
し、乳化機にて乳化した。乳化物を30℃まで冷却し製
品とした。(Production method) (1) to (6) were heated and stirred at 70 ° C. to obtain an oil phase part. (7) to (9) were heated to 70 ° C. to completely dissolve them, and then used as an aqueous phase part. The oil phase part was added to the water phase part and emulsified with an emulsifier. The emulsion was cooled to 30 ° C. to obtain a product.
【0056】比較例3 実施例7の処方中(4)を除く以外は実施例7と同様に
して製品を得た。Comparative Example 3 A product was obtained in the same manner as in Example 7, except that (4) was excluded from the formulation of Example 7.
【0057】以上の如くして得られた実施例5〜7およ
び比較例1〜3について紫外線防止効果の測定を行っ
た。測定方法は、人の背部に本発明品を配合した上記化
粧料を2mg/cm2の量で塗布し、15分後UV−A照射を
行った。UV−A照射は、BLBランプで、365nm、
9J/cm2 のエネルギー量の紫外線を照射し、下記の式
を用いて最小黒化量(MMD)を求めた。With respect to Examples 5 to 7 and Comparative Examples 1 to 3 obtained as described above, the ultraviolet protection effect was measured. As the measuring method, the above-mentioned cosmetic containing the product of the present invention was applied to the back of a person in an amount of 2 mg / cm 2 , and after 15 minutes, UV-A irradiation was performed. UV-A irradiation is performed with a BLB lamp at 365 nm,
Ultraviolet rays having an energy amount of 9 J / cm 2 were irradiated and the minimum blackening amount (MMD) was obtained using the following formula.
【0058】[0058]
【数1】 [Equation 1]
【0059】この結果を表1に示した。The results are shown in Table 1.
【0060】[0060]
【表1】 [Table 1]
【0061】表1からわかるように実施例のMMD値
は、いずれも比較例より高くなっている。すなわち、本
発明のシリコーン系ヒダントイン誘導体を配合すること
により優れた紫外線防止効果が得られることがわかる。As can be seen from Table 1, the MMD values of the examples are higher than those of the comparative examples. That is, it can be seen that an excellent UV protection effect can be obtained by adding the silicone-based hydantoin derivative of the present invention.
【0062】[0062]
【発明の効果】本発明のシリコーン系ヒダントイン誘導
体は、UV−A領域に極大吸収を有する優れた紫外線吸
収剤である。また、本発明の紫外線吸収剤は、耐水性、
耐油性に優れているので、基剤や他の配合成分を自由に
選べる皮膚外用剤を提供することができると同時に、日
焼け止め化粧料として炎天下の過酷な条件下に曝露した
場合においても優れた効果を示すことは明らかである。The silicone hydantoin derivative of the present invention is an excellent ultraviolet absorber having a maximum absorption in the UV-A region. Further, the ultraviolet absorbent of the present invention is water resistant,
Since it has excellent oil resistance, it can provide a skin external preparation whose base and other components can be freely selected, and at the same time, it is excellent as a sunscreen cosmetic even when exposed to the harsh conditions under hot weather. It is clear that it has an effect.
【図1】本発明の実施例1で得られたシリコーン系ヒダ
ントイン誘導体化7の 1H−NMRスペクトルを示す図
である。FIG. 1 is a diagram showing a 1 H-NMR spectrum of a silicone-based hydantoin derivatization 7 obtained in Example 1 of the present invention.
【図2】本発明の実施例1で得られたシリコーン系ヒダ
ントイン誘導体化7の赤外吸収スペクトルを示す図であ
る。FIG. 2 is a diagram showing an infrared absorption spectrum of silicone-based hydantoin derivatization 7 obtained in Example 1 of the present invention.
【図3】本発明の実施例1で得られたシリコーン系ヒダ
ントイン誘導体化7の紫外線吸収スペクトルを示す図で
ある。FIG. 3 is a diagram showing an ultraviolet absorption spectrum of silicone-based hydantoin derivatization 7 obtained in Example 1 of the present invention.
Claims (3)
トリメチルシロキシ基、R2 およびR3 はアルキレン基
またはオキシアルキレン基、Xは水酸基、炭素数1〜8
のアルキル基または炭素数1〜8のアルコキシ基、mは
0〜3の整数、aは0〜5の整数を表す。)で表される
単位を少なくとも1個持つシロキサン類であって、前記
シロキサン類中に存在し得る他の単位が、一般式O
(4-n)/2 SiR4 n (nは0〜3の整数、R4 は炭素数
1〜4のアルキル基、フェニル基またはトリメチルシロ
キシ基を表す。)で表されることを特徴とするシリコー
ン系ヒダントイン誘導体。1. A compound represented by the general formula (1): (R 1 is an alkyl group having 1 to 4 carbon atoms, a phenyl group or a trimethylsiloxy group, R 2 and R 3 are alkylene groups or oxyalkylene groups, X is a hydroxyl group, and 1 to 8 carbon atoms.
Is an alkyl group or an alkoxy group having 1 to 8 carbon atoms, m is an integer of 0 to 3, and a is an integer of 0 to 5. ) A siloxane having at least one unit represented by the formula (4), and the other units that may be present in the siloxane are represented by the general formula O
(4-n) / 2 SiR 4 n (n is an integer of 0 to 3 and R 4 is an alkyl group having 1 to 4 carbon atoms, a phenyl group or a trimethylsiloxy group). Silicone hydantoin derivative.
ン誘導体からなる紫外線吸収剤。2. An ultraviolet absorber comprising the silicone hydantoin derivative according to claim 1.
ン誘導体を含有することを特徴とする皮膚外用剤。3. An external preparation for skin comprising the silicone hydantoin derivative according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26583993A JP3178951B2 (en) | 1993-09-28 | 1993-09-28 | Silicone hydantoin derivatives, UV absorbers and skin external preparations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26583993A JP3178951B2 (en) | 1993-09-28 | 1993-09-28 | Silicone hydantoin derivatives, UV absorbers and skin external preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0797384A true JPH0797384A (en) | 1995-04-11 |
JP3178951B2 JP3178951B2 (en) | 2001-06-25 |
Family
ID=17422786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP26583993A Expired - Fee Related JP3178951B2 (en) | 1993-09-28 | 1993-09-28 | Silicone hydantoin derivatives, UV absorbers and skin external preparations |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3178951B2 (en) |
-
1993
- 1993-09-28 JP JP26583993A patent/JP3178951B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3178951B2 (en) | 2001-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6376679B2 (en) | Photoprotective/cosmetic compositions comprising novel benz-x-azole-substituted silane/siloxane sunscreens | |
AU616538B2 (en) | Silicone type cinnamic acid derivative, preparation method thereof, uv-ray absorber, and external skin treatment agent | |
KR100294726B1 (en) | Benzophenone derivatives, UV absorbers and external skin preparations | |
PL181264B1 (en) | New solar filters containing photo protective cosmetic compounds and their application | |
JP2984300B2 (en) | Cosmetic composition | |
US5061479A (en) | Use of diorganopolysiloxanes containing a 3-benzylidene camphor functional group in cosmetics and new cosmetic compositions containing these compounds, intended for protecting the skin and hair | |
US5315022A (en) | Silicone type cinnamic acid derivative, preparation method thereof, UV-ray absorber, and external skin treatment agent | |
JP3088224B2 (en) | Silicone hydantoin derivatives, UV absorbers and skin external preparations | |
JP3178951B2 (en) | Silicone hydantoin derivatives, UV absorbers and skin external preparations | |
JP3229383B2 (en) | Alkyl-aryl 1,3-propanedione silicone derivative and external preparation for skin containing the same | |
US5225583A (en) | Alkyl-aryl 1,3-propanedione silicone derivative and an external preparation for skin with the derivative compounded therein | |
JP3145237B2 (en) | Silicone hydantoin derivatives, UV absorbers and skin external preparations | |
JP3170386B2 (en) | Silicone hydantoin derivatives, UV absorbers and skin external preparations | |
JP3088222B2 (en) | UV absorber and external preparation for skin | |
JP2860305B2 (en) | External preparation for skin | |
JP3162878B2 (en) | Silicone cinnamic acid derivatives, UV absorbers and skin external preparations | |
JP3170389B2 (en) | Silicone hydantoin derivatives, UV absorbers and skin external preparations | |
EP2488569B1 (en) | A silicone compound | |
JP3088223B2 (en) | UV absorber and external preparation for skin | |
JPH0717983A (en) | 5-allylpentadienoic acid silicon derivative, ultraviloet rays absorbent and skin external agent compounded with the same | |
JPH049355A (en) | Cinnamic acid derivative, uv absorber and dermatic external drug containing the same | |
JPH07238275A (en) | Ultraviolet light absorber and skin external preparation containing the same blended therein | |
JPH06228167A (en) | Organosilicon derivative and external preparation for skin | |
JPH0717892A (en) | 1,3-butadienyl ketone derivative, ultraviolet ray absorber and skin external preparation containing the same blended therein | |
JPH07330779A (en) | Benzalmalonate derivative having organic silicon group, its production and ultraviolet absorber and cosmetic containing the derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |